Company
Perrigo
Perrigo has 11 drugs tracked on RxWires: 7 approved, 1 in Phase 3, 1 in Phase 1/2, 2 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| MINOXIDIL EXTRA STRENGTH (FOR MEN) | Approved | |
| BETAMETHASONE VALERATE | Approved | |
| KIRKLAND SIGNATURE QUIT 4 | Approved | |
| IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Approved | |
| RANITIDINE HYDROCHLORIDE | Approved | |
| ANTI DIARRHEAL ANTI GAS | Approved | |
| MEPROBAMATE | Approved | |
| pseudoephedrine hydrochloride 30 mg tablets | Phase 3 | Nasal Congestion Associated With the Common Cold |
| Vivomixx | Phase 1/2 | Breast Cancer |
| Naproxen Tablets, 500 mg | Phase 1 | Bioequivalency |
| Famotidine Tablets, 40 mg | Phase 1 | Bioavailability |
Latest
- Label updated: NICOTINE POLACRILEX
- perrigo filed 8-K
- perrigo filed 8-K
- perrigo filed 8-K
- perrigo filed 8-K
Follow Perrigo on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.